Low-density lipoproteins (LDLs) represent a novel class of nanocarriers for the targeted delivery of therapeutics into aberrant cells that overexpress the LDL receptor. Here we report a facile procedure for reconstituting the hydrophobic core of LDLs with a binary fatty acid mixture. Facilitated by the tumor targeting capability of the apolipoprotein, the reconstituted, drug-loaded LDLs can effectively target cancer cells that overexpress the LDL receptor while showing minor adverse impact on normal fibroblasts. According to a hypothesized mechanism, the reconstituted LDLs can also enable metabolism-triggered drug release while preventing the payloads from lysosomal degradation. This study demonstrates that LDLs reconstructed with fatty acids hold great promise to serve as effective and versatile nanocarriers for targeted cancer therapy.
[NMR paper] Targeted Molecular Imaging of Cancer Cells Using MS2-Based (129)Xe NMR.
Targeted Molecular Imaging of Cancer Cells Using MS2-Based (129)Xe NMR.
http://www.bionmr.com//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--pubs.acs.org-images-pubmed-acspubs.jpg Related Articles Targeted Molecular Imaging of Cancer Cells Using MS2-Based (129)Xe NMR.
Bioconjug Chem. 2016 Aug 17;27(8):1796-801
Authors: Jeong K, Netirojjanakul C, Munch HK, Sun J, Finbloom JA, Wemmer DE, Pines A, Francis MB
Abstract
We have synthesized targeted, selective, and highly sensitive (129)Xe NMR nanoscale biosensors using a...